Multimedia

Dan Gemp, president and CEO of Dreamscape Marketing, is on the BHE Podcast to discuss how marketers in behavioral healthcare need to use data and hindsight in their strategic planning to address some seismic changes that have been occurring as big, new players enter the industry.

W. Clay Jackson, MD, DipTh, of the University of Tennessee College of Medicine in Memphis, discusses treatment approaches for patients with depression and substance use disorders.

Michael Thase, MD, discusses the use of second-generation antipsychotics as an adjunctive therapy in depression.

Michael Thase, MD, provides details on the strategy of combining antidepressants when treating patients with depression.

Chuck Ingoglia, MSW, joins the BHE Podcast to discuss how he has settled into his role as president and CEO of the National Council for Behavioral Health since taking the position on June 1.

Joe Pritchard, CEO of Pinnacle Treatment Centers, discusses how an integrated hub-and-spoke care delivery system allows the organization to be impactful in the communities it enters with regards to legislation, regulation and payer relationships.

Tani Weiner, JD, shareholder and vice-chair of the behavioral health law group at Polsinelli LLP, and Edith Bauer, Esq., general counsel at Discovery Behavioral Health, discuss issues around reimbursement for behavioral healthcare providers.

W. Clay Jackson, MD, DipTh, explains the difference between major depressive disorder and major depressive disorder with mixed features.

Krista Gilbert, PhD, LMFT, joins the BHE Podcast to discuss transitioning from her early career aspirations of being, in her words, “a therapist for life” to her current role as chief executive officer of Constellation Behavioral Health.

Sanjay J. Mathew, MD, speaks about best practices for administering esketamine during his Psych Congress 2019 presentation "Top 5 Issues Clinicians Should Know about Ketamine Therapy."